Home › Funds › PFM Health Sciences, LP › NVO

PFM Health Sciences, LP position in NVO

NOVO-NORDISK A S · Health Care

PFM Health Sciences, LP reported holding 265,016 shares of NVO (NOVO-NORDISK A S) in its Q2 2026 13F filing — a position valued at US$12.7M, representing 1.11% of its reported portfolio and ranking #33 among its reported holdings. PFM Health Sciences, LP has disclosed NVO holdings in 3 of the last 7 reported quarters, going back to Q4 2024.

Latest position (Q2 2026)265.02K sh
Reported value held$12.70M
Portfolio Weight1.11%
First reportedQ4 2024
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How PFM Health Sciences, LP's NVO position evolved

PFM Health Sciences, LP first disclosed a stake in NVO in Q4 2024 at 334,900 shares (US$28.8M). Across 3 filings, PFM Health Sciences, LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 265,016 shares valued at US$12.7M — an increase of 67,835 shares quarter over quarter.. Notable position changes include a 34% increase in Q2 2026 (shares fell 21% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 334.90K $28.81M New
Q1 2026 197.18K $7.25M New
Q2 2026 265.02K $12.70M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NVO and 13F data

NVO (NOVO-NORDISK A S) is a Health Care company. 15 other funds we track also report a position in NVO — the largest reported positions include LOOMIS SAYLES & CO L P (US$891.4M), FOLKETRYGDFONDET (US$456.5M), EVERETT HARRIS & CO /CA/ (US$310.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NVO

All NVO fund holders →

FAQ

How long has PFM Health Sciences, LP held NVO?

PFM Health Sciences, LP has disclosed NVO holdings in 3 of the last 7 reported quarters, going back to Q4 2024.

What is PFM Health Sciences, LP's current position in NVO?

As of Q2 2026, PFM Health Sciences, LP holds 265.02K shares of NVO (NOVO-NORDISK A S), valued at $12.70M, representing 1.11% of its reported portfolio and ranking #33.

Has PFM Health Sciences, LP been buying or selling NVO?

In the latest 13F filing (Q2 2026), PFM Health Sciences, LP increased its position in NVO.

Which other funds hold NVO?

Other major institutional holders of NVO include LOOMIS SAYLES & CO L P, FOLKETRYGDFONDET, EVERETT HARRIS & CO /CA/, among 15 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.